Monte Rosa Therapeutics (GLUE) Earnings (2020 - 2026)
Monte Rosa Therapeutics (GLUE) earnings from Mar 31, 2020 to Mar 31, 2026. The TTM Monte Rosa Therapeutics (GLUE) earnings is -$122M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Monte Rosa Therapeutics (GLUE) Earnings CAGR table
| Period | CAGR |
|---|---|
| 3 Years TTM | +1.65% |
| 5 Years TTM | +22.80% |
| All Time TTM | +22.81% |
Annual Earnings change of Monte Rosa Therapeutics (GLUE)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$45M | +15.20% |
| 2025 | -$39M | -46.86% |
| 2024 | -$73M | -46.29% |
| 2023 | -$135M | +24.75% |
| 2022 | -$109M | +46.70% |
| 2021 | -$74M | +106.13% |
| 2020 | -$36M | N/A |
Comparison Monte Rosa Therapeutics (GLUE) five years earnings CAGR with competitors
Monte Rosa Therapeutics (GLUE) five years earnings CAGR is 22.80%.